Thursday, 3 March 2022

Reuters Global Healthcare: EXCLUSIVE Illumina remedies on Grail bid unconvincing to EU antitrust regulators, sources say

EXCLUSIVE Illumina remedies on Grail bid unconvincing to EU antitrust regulators, sources say

U.S. life sciences company Illumina's offer to cut prices and allow rivals continued access to its technologies has "yet to convince" EU antitrust regulators scrutinising its $8 billion cash-and-stock bid for Grail Inc , people familiar with the matter said.

COVID curbs linked to 720,000 fewer dengue fever cases in 2020 - study

COVID-19-related restrictions on people's movements and interactions may be linked to a sharp decline in cases of mosquito-borne dengue fever in 2020, offering new insight into how it might be controlled, according to a study.

Sacklers to pay $6 bln to settle Purdue opioid lawsuits

The Sackler family owners of Purdue Pharma LP reached a deal with a group of attorneys general to pay up to $6 billion in cash to resolve widespread litigation alleging that they fueled the U.S. opioid epidemic, bringing the OxyContin maker closer to exiting bankruptcy.

Nearly 3 mln Malawian children to get polio shot after rare outbreak

Medics will vaccinate about 2.9 million young children against polio in Malawi, the United Nations said on Thursday, after a three-year-old girl fell sick in the capital with Africa's first case of wild poliovirus in more than five years.

Austrian health minister Mueckstein resigns

Austrian Health Minister Wolfgang Mueckstein resigned on Thursday, the second top official to step down within a year under the strain of tackling the coronavirus pandemic.

U.S. Supreme Court lets Republican defend Kentucky abortion curbs

The U.S. Supreme Court on Thursday let Kentucky's Republican attorney general seek to restore a restrictive abortion law after the state's Democratic governor dropped defense of the statute when lower courts struck it down.

Arthritis drug shown to reduce risk of COVID death in large UK trial

Eli Lilly and Incyte's arthritis drug baricitinib helped reduce the risk of death in hospitalised COVID-19 patients by 13% regardless of which other coronavirus treatment they were given, according to a large British study.

Drugmakers, device companies say sanctions may hinder medical supplies to Russia

Western drugmakers and medical device companies warn their plans to keep selling products to Russia may be complicated by economic sanctions targeting the country and its major banks in punishment over Moscow's invasion of Ukraine.

Sweden sees clear drop in COVID cases despite scrapped curbs

COVID-19 cases in Sweden are falling sharply, the country's health agency said on Thursday, even as nearly all pandemic-related restrictions were lifted less than a month ago.

EMA says not concerned by New York state data on Pfizer/BioNTech vaccine

The European Medicines Agency's leading vaccine expert said he was not concerned over recent data from New York state on a decline of protection from the Pfizer and BioNTech SE COVID-19 vaccine in children aged 5 to 11.

Related Videos

Making heart health a priority for Black women

AstraZeneca shelf life hurts rollout for world's poorest

Easing COVID curbs could cause 2 mln deaths: China study